Stay updated on Emicizumab Prophylaxis in Hemophilia A Clinical Trial

Sign up to get notified when there's something new on the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record presents details and results for the completed HAVEN 3 trial evaluating emicizumab prophylaxis for people with hemophilia A without inhibitors. It also includes eligibility criteria, study locations, publications, and study documents.
    Difference
    89%
    Check dated 2026-11-08T05:23:52.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error rather than trial details.
    Difference
    0.2%
    Check dated 2026-11-01T03:14:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T03:17:27.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T03:09:18.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T05:13:52.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous content with an access-restricted message. A Home link is displayed, indicating the resource cannot be viewed at this time.
    Difference
    21%
    Check dated 2026-09-20T02:00:26.000Z thumbnail image

Stay in the know with updates to Emicizumab Prophylaxis in Hemophilia A Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page.